|
Edwin Stone
CEO
Cellular Origins
Melbourn
|
After completing his PhD in robotic vehicles at University of Cambridge, Edwin has spent 20 years bringing new life science technologies to market. He has worked with over 30 start-ups who have collectively raised in excess of $1Bn and achieved exits of up to 20X on investment. For the last 10 years, he has focused on cell therapy manufacturing, where he established TTP’s cell and gene team growing it to 20 people and achieving a CAGR of 50%. He has been involved with the development of over 10 cell therapy automation systems, which are now in use for therapeutic manufacture. Seeing the challenge of scale remained unaddressed, Edwin co-founded Cellular Origins where he is passionate about enabling patient access to cell therapies through scalable, cost-effective and space efficient manufacturing enabled by the Constellation™ automated cell therapy manufacturing platform.